<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39377094</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>High-flow humidified oxygen as an early intervention in children with acute severe asthma: a feasibility randomised controlled trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00168-2024</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00168-2024</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Treating children with acute severe asthma (ASA) who fail to respond to first-line inhaled bronchodilators is problematic: use of intravenous agents is inconsistent and side-effects are common. High-flow humidified oxygen (HiFlo) has shown promise in other respiratory conditions and is increasingly used in ASA, but with little evidence.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a feasibility randomised controlled trial with deferred consent to assess early HiFlo in children aged 2-11 years with ASA not responding to "burst" therapy (high-dose inhaled salbutamol ± ipratropium). Children with Paediatric Respiratory Assessment Measure (PRAM) score 5+ after "burst" were randomised to commence HiFlo or follow standard care. Candidate primary outcomes assessed were treatment failure requiring escalation, and time to meeting hospital discharge criteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The target was met despite coronavirus disease 2019 pandemic disruption: 56 children were randomised across four sites, with deferred consent received in 50 out of 56 (89%), and mean recruitment rate 1.1 per site per month. 28 were allocated early HiFlo and 22 standard care. Data collection was complete for both candidate primary outcomes. Treatment failure requiring escalation occurred in 18 of 28 children (64%) in the HiFlo arm and in 19 of 22 (86%) in the standard care arm. Median (interquartile range) time from randomisation to meeting discharge criteria was 29.3 h (21.8-43.7 h) in the HiFlo arm and 36.8 h (24.1-46.3 h) in the standard care arm.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">HiFlo in childhood ASA is a potentially promising intervention whose use is increasing despite lack of evidence. A definitive randomised controlled trial to assess its effectiveness is required and appears to be feasible.</AbstractText><CopyrightInformation>Copyright ©The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kapur</LastName><ForeName>Akshat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospitals Sussex NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Anaya</LastName><ForeName>Héctor</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospitals Sussex NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brighton and Sussex Clinical Trials Unit, Brighton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sussex Medical School, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Graham</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2252-1248</Identifier><AffiliationInfo><Affiliation>University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roland</LastName><ForeName>Damian</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9334-5144</Identifier><AffiliationInfo><Affiliation>Children's Emergency Department, Leicester Royal Infirmary, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Atul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King's College Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazner</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospitals Sussex NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayreuther</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Southampton NHS Foundation Trust, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Southampton Faculty of Medicine, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantle</LastName><ForeName>Fleur</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>King's College Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Christina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3672-6631</Identifier><AffiliationInfo><Affiliation>School of Psychology, University of Surrey, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappachan</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Southampton NHS Foundation Trust, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Southampton Faculty of Medicine, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bremner</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brighton and Sussex Clinical Trials Unit, Brighton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sussex Medical School, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Southampton NHS Foundation Trust, Southampton, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Southampton Faculty of Medicine, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Shane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Children's Emergency Department, Leicester Royal Infirmary, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owens</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospitals Sussex NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asim</LastName><ForeName>Lalarukh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>King's College Hospital NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaleva</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seddon</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2136-958X</Identifier><AffiliationInfo><Affiliation>University Hospitals Sussex NHS Foundation Trust, Brighton, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: A. Kapur has nothing to disclose. Conflict of interest: H. Rojas-Anaya has nothing to disclose. Conflict of interest: G. Roberts has nothing to disclose. Conflict of interest: D. Roland has nothing to disclose. Conflict of interest: A. Gupta has nothing to disclose. Conflict of interest: M. Lazner was an advisory board member for Aerogen Ltd for non-HiFlo study-related research and received an honorarium of £952.89 for this work. Conflict of interest: J. Bayreuther has nothing to disclose. Conflict of interest: F. Cantle has nothing to disclose. Conflict of interest: C. Jones has nothing to disclose. Conflict of interest: J. Pappachan has nothing to disclose. Conflict of interest: S. Bremner has nothing to disclose. Conflict of interest: D. James has nothing to disclose. Conflict of interest: S. Fitzgerald has nothing to disclose. Conflict of interest: K. Owens has nothing to disclose. Conflict of interest: L. Asim has nothing to disclose. Conflict of interest: E. Khaleva has nothing to disclose. Conflict of interest: P. Seddon, in March 2023, chaired an advisory board (unrelated to HiFlo) for Aerogen Ltd, which loaned nebuliser equipment for the study, and received an honorarium.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39377094</ArticleId><ArticleId IdType="pmc">PMC11456965</ArticleId><ArticleId IdType="doi">10.1183/23120541.00168-2024</ArticleId><ArticleId IdType="pii">00168-2024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chawla J, Seear M, Zhang T, et al. . Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources? Pediatr Pulmonol 2012; 47: 211–219. doi:10.1002/ppul.21537</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.21537</ArticleId><ArticleId IdType="pubmed">21905263</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill C, Owens PL. Reasons for being admitted to the hospital through the emergency department for children and adolescents, 2004: Statistical Brief #33. In:
Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, Agency for Healthcare Research and Quality, 2007. www.ncbi.nlm.nih.gov/books/NBK61976/</Citation><ArticleIdList><ArticleId IdType="pubmed">21850774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallis C, Maslova E, Morgan AD, et al. . Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study. Thorax 2023; 78: 1175–1180. doi:10.1136/thorax-2022-219757</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax-2022-219757</ArticleId><ArticleId IdType="pmc">PMC10715559</ArticleId><ArticleId IdType="pubmed">37524391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha I, Latchem S, Amusan L, et al.  National Asthma and COPD Audit Programme: Children and young people asthma clinical and organisational audit 2019/20. Combined clinical and organisational audit of children and young people asthma services in England, Scotland and Wales. London, Royal College of Physicians, 2021. www.nrap.org.uk/NRAP/welcome.nsf/0/FD67A41147AF27E4802586D80055CC2F/$file/CYPAA_combined_national_clinical_and_organisational_audit_report_May_2021.pdf</Citation></Reference><Reference><Citation>British Thoracic Society ( BTS)/Scottish Intercollegiate Guidelines Network (SIGN). SIGN 158: British Guideline on the Management of Asthma. 2019. www.sign.ac.uk/media/1773/sign158-updated.pdf</Citation></Reference><Reference><Citation>Global Initiative for Asthma (GINA) . Global Strategy for Asthma Management and Prevention, 2023. Date last accessed: 1 August 2024. www.ginasthma.org</Citation></Reference><Reference><Citation>Haq I, Gopalakaje S, Fenton AC, et al. . The evidence for high flow nasal cannula devices in infants. Paediatr Respir Rev 2014; 15: 124–134.</Citation><ArticleIdList><ArticleId IdType="pubmed">24472697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilliard TN, Archer N, Laura H, et al. . Pilot study of vapotherm oxygen delivery in moderately severe bronchiolitis. Arch Dis Child 2012; 97: 182–183. doi:10.1136/archdischild-2011-301151</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2011-301151</ArticleId><ArticleId IdType="pubmed">22100741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kepreotes E, Whitehead B, Attia J, et al. . High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial. Lancet 2017; 389: 930–939. doi:10.1016/S0140-6736(17)30061-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30061-2</ArticleId><ArticleId IdType="pubmed">28161016</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin D, Babl FE, Schlapbach LJ, et al. . A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med 2018; 378: 1121–1131. doi:10.1056/NEJMoa1714855</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1714855</ArticleId><ArticleId IdType="pubmed">29562151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramnarayan P, Richards-Belle A, Drikite L, et al. . Effect of high-flow nasal cannula therapy vs continuous positive airway pressure therapy on liberation from respiratory support in acutely ill children admitted to pediatric critical care units: a randomized clinical trial. JAMA 2022; 328: 162–172. doi:10.1001/jama.2022.9615</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.9615</ArticleId><ArticleId IdType="pmc">PMC9204623</ArticleId><ArticleId IdType="pubmed">35707984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao KY, Chien YH, Mu SC. High-flow nasal cannula in children with asthma exacerbation: a review of current evidence. Paediatr Respir Rev 2021; 40: 52–57.</Citation><ArticleIdList><ArticleId IdType="pubmed">33771473</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudin F, Buisson A, Vanel B, et al. . Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care 2017; 7: 55. doi:10.1186/s13613-017-0278-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-017-0278-1</ArticleId><ArticleId IdType="pmc">PMC5440424</ArticleId><ArticleId IdType="pubmed">28534235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Martinez F, Gonzalez Sanchez MI, Toledo Del Castillo B, et al. . Tratamiento con oxigenoterapia de alto flujo en las crisis asmáticas en la planta de hospitalización de pediatría: nuestra experiencia [Treatment with high-flow oxygen therapy in asthma exacerbations in a paediatric hospital ward: experience from 2012 to 2016]. An Pediatr (Engl Ed) 2019; 90: 72–78. doi:10.1016/j.anpedi.2018.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anpedi.2018.06.015</ArticleId><ArticleId IdType="pubmed">30322768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilar J, Modesto IAV, Lopez-Fernandez YM, et al. . High-flow nasal cannula therapy versus non-invasive ventilation in children with severe acute asthma exacerbation: an observational cohort study. Med Intensiva 2017; 41: 418–424. doi:10.1016/j.medin.2017.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medin.2017.01.001</ArticleId><ArticleId IdType="pubmed">28216104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballestero Y, De Pedro J, Portillo N, et al. . Pilot clinical trial of high-flow oxygen therapy in children with asthma in the emergency service. J Pediatr 2018; 194: 204–210.e3. doi:10.1016/j.jpeds.2017.10.075</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2017.10.075</ArticleId><ArticleId IdType="pubmed">29331328</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauto Benítez R, Morilla Sanabria LP, Pavlicich V, et al. . High flow nasal cannula oxygen therapy in patients with asthmatic crisis in the pediatric emergency department. Rev Chil Pediatr 2019; 90: 642–648.</Citation><ArticleIdList><ArticleId IdType="pubmed">32186587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalut DS, Ducharme FM, Davis GM. The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity. J Pediatr 2000; 137: 762–768. doi:10.1067/mpd.2000.110121</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2000.110121</ArticleId><ArticleId IdType="pubmed">11113831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducharme FM, Chalut D, Plotnick L, et al. . The Pediatric Respiratory Assessment Measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers. J Pediatr 2008; 152: 476–480.e1. doi:10.1016/j.jpeds.2007.08.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2007.08.034</ArticleId><ArticleId IdType="pubmed">18346499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Anaya H, Kapur A, Roberts G, et al. . High-flow humidified oxygen as an early intervention in children with acute severe asthma: protocol for a feasibility randomized controlled trial. JMIR Res Protoc 2024; 13: e54081. doi:10.2196/54081</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/54081</ArticleId><ArticleId IdType="pmc">PMC11009849</ArticleId><ArticleId IdType="pubmed">38546733</ArticleId></ArticleIdList></Reference><Reference><Citation>Harron K, Woolfall K, Dwan K, et al. . Deferred consent for randomized controlled trials in emergency care settings. Pediatrics 2015; 136: e1316–e1322. doi:10.1542/peds.2015-0512</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-0512</ArticleId><ArticleId IdType="pubmed">26438711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyttle MD, Rainford NEA, Gamble C, et al. . Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet 2019; 393: 2125–2134. doi:10.1016/S0140-6736(19)30724-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30724-X</ArticleId><ArticleId IdType="pmc">PMC6551349</ArticleId><ArticleId IdType="pubmed">31005385</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol 2012; 65: 301–308. doi:10.1016/j.jclinepi.2011.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.07.011</ArticleId><ArticleId IdType="pubmed">22169081</ArticleId></ArticleIdList></Reference><Reference><Citation>Teare MD, Dimairo M, Shephard N, et al. . Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials 2014; 15: 264. doi:10.1186/1745-6215-15-264</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-15-264</ArticleId><ArticleId IdType="pmc">PMC4227298</ArticleId><ArticleId IdType="pubmed">24993581</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldridge SM, Chan CL, Campbell MJ, et al. . CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 2016; 355: i5239. doi:10.1136/bmj.i5239</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i5239</ArticleId><ArticleId IdType="pmc">PMC5076380</ArticleId><ArticleId IdType="pubmed">27777223</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko J, King C, Harkness D, et al. . Pediatric acute asthma scoring systems: a systematic review and survey of UK practice. J Am Coll Emerg Physicians Open 2020; 1: 1000–1008. doi:10.1002/emp2.12083</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emp2.12083</ArticleId><ArticleId IdType="pmc">PMC7593416</ArticleId><ArticleId IdType="pubmed">33145551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>